Ranibizumab ophthalmic and Increased intraocular pressure
Result of checking the interaction of drug Ranibizumab ophthalmic and disease Increased intraocular pressure for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Increases in intraocular pressure have been reported both pre- injection and post- injection (at 60 minutes) while being treated with ranibizumab. Intraocular pressure should be monitored prior and following intravitreal injection with ranibizumab and managed appropriately.
Generic Name: ranibizumab ophthalmic
Brand Name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Ranibizumab ophthalmic - zwiększone ciśnienie wewnątrzgałkowe 
Ranibizumab ophthalmic - aumento da pressão intraocular 
Ranibizumab ophthalmic - peningkatan tekanan intraokular 
Ranibizumab ophthalmic - peningkatan tekanan intraokular 
Ranibizumab ophthalmic - aumento della pressione intraoculare 
Ranibizumab ophthalmic - augmentation de la pression intraoculaire 
Ranibizumab ophthalmic - erhöhter Augeninnendruck 
Ranibizumab ophthalmic - aumento de la presión intraocular 
Ranibizumab ophthalmic - повышенное внутриглазное давление 
Ranibizumab ophthalmic - artan göz içi basıncı 
Ranibizumab ophthalmic - زيادة ضغط العين 
Ranibizumab ophthalmic - 眼内压升高